Physician profile
Joseph Karam
NPI 1942430491
$88,319.37
in general payments reported to CMS, 2019-2025
14 companies · $2,213 in 2025
The $2,213 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,791 · 2020: $6,958 · 2021: $11K · 2022: $28K · 2023: $9,945 · 2024: $20K · 2025: $2,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Honoraria: $3,315 · Travel and Lodging: $2,162 · Food and Beverage: $1,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,830.00 |
| Honoraria | $3,315.00 |
| Travel and Lodging | $2,161.78 |
| Food and Beverage | $1,843.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36,244.18 | 2021-2022 | |
| Philips North America LLC | $25,794.09 | 2021-2024 | (9520) Igt Devices Undivided, (6554) Periph Vasc Undiv, (Bh4) Igt Devices Undivided |
| Medtronic Vascular, INC. | $12,483.70 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $9,520.89 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Viabahn Endoprosthesis With Propaten Bioactive Surface, Gore Viabahn Endoprosthesis |
| Integer Holdings Corporation | $2,800.00 | 2019-2020 | |
| Silk Road Medical, INC. | $886.18 | 2020 | |
| Intuitive Surgical, INC. | $230.55 | 2022-2023 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $183.27 | 2021-2024 | Renasys Touch |
| Bolton Medical INC | $95.12 | 2019 | |
| Tela Bio, INC. | $51.95 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Stryker Corporation | $16.19 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Globus Medical, INC. | $13.25 | 2024 | Tibial Nail |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Karam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.